Refine
Has Fulltext
- yes (229)
Is part of the Bibliography
- yes (229)
Year of publication
Document Type
- Journal article (213)
- Conference Proceeding (11)
- Doctoral Thesis (4)
- Other (1)
Language
- English (229) (remove)
Keywords
- Chirurgie (26)
- Medizin (9)
- inflammation (9)
- Immunbiologie (8)
- colorectal cancer (8)
- obesity (8)
- cytokines (6)
- Immunobiologie (4)
- Roux-en-Y gastric bypass surgery (4)
- bariatric surgery (4)
- inflammatory bowel disease (4)
- Ureaplasma parvum (3)
- anastomotic leakage (3)
- chemotherapy (3)
- evidence-based medicine (3)
- guidelines (3)
- incisional hernia (3)
- indication for surgery (3)
- intestinal epithelial barrier (3)
- laparoscopic ventral hernia repair (3)
- liraglutide (3)
- open abdomen (3)
- perioperative management (3)
- sepsis (3)
- 5-Fluorouracil (2)
- Aspergillus (2)
- COVID-19 (2)
- CRC (2)
- Caco2 cells (2)
- Cancer (2)
- Crohn's disease (2)
- DNA damage (2)
- Fn14 (2)
- Germany (2)
- Krebs (2)
- Krebs <Medizin> (2)
- Langerhans-Inseln (2)
- NAFLD (2)
- NFκB (2)
- Rectal cancer (2)
- SARS-CoV-2 (2)
- Surgery (2)
- TWEAK (2)
- Transplantation (2)
- Ureaplasma urealyticum (2)
- adaptive immunity (2)
- adrenocortical carcinoma (2)
- agonistic antibodies (2)
- animal model (2)
- anticoagulation (2)
- antimicrobial stewardship (2)
- atrial fibrillation (2)
- biomarker (2)
- bridging (2)
- cancer (2)
- case report (2)
- cell death (2)
- complication (2)
- dendritic cells (2)
- desmosome (2)
- endoluminal (2)
- enzyme activation (2)
- enzyme inhibitors (2)
- extracorporeal membrane oxygenation (2)
- gastric bypass (2)
- gastric cancer (2)
- giant ventral hernia (2)
- gut barrier (2)
- ileocecal resection (2)
- immunoassay (2)
- ischemia (2)
- islets of Langerhans (2)
- laparostomy (2)
- malignant melanoma (2)
- meta-analysis (2)
- metastasis (2)
- microbial spectrum (2)
- mortality (2)
- negative pressure (2)
- oxaliplatin (2)
- pancreatic cancer (2)
- parastomal hernia (2)
- pediatric (2)
- peptide tyrosine tyrosine (PYY) (2)
- peritoneal carcinomatosis (2)
- phosphodiesterase (2)
- postoperative bleeding (2)
- preterm infants (2)
- primary ventral hernia (2)
- rat (2)
- rectum (2)
- skin (2)
- surgery (2)
- surgical therapy (2)
- swine (2)
- synthetic mesh (2)
- therapy (2)
- thromboembolism (2)
- translational research (2)
- treatment (2)
- umbilical hernia (2)
- vacuum conditioning (2)
- vacuum-assisted closure (2)
- ventral hernia (2)
- 15-Deoxyspergualin (1)
- 1st-line treatment (1)
- 5-fluorouracil (1)
- 6-percent hydroxyethyl starch (1)
- AAA (1)
- ALCL (1)
- Activation (1)
- Adrenocortical Carcinoma (1)
- Allergie (1)
- Allopeptidb (1)
- Allotransplantatabstossung (1)
- Apoptosis (1)
- Attentional performance (1)
- Autologous (1)
- BM (1)
- Barrett-Ösophagus (1)
- Bauchspeicheldrüsenkrebs (1)
- Beta-catenin (1)
- Blood–brain barrier (1)
- Brain μ-opioid receptors (1)
- C-MYC (1)
- CA19-9 (1)
- CASP (1)
- CCR7 (1)
- CD62L (1)
- CNS integrity (1)
- COVID-19 pandemic (1)
- CT angiography (1)
- CX3CL1 (1)
- CX5461 (1)
- CXCL13 (1)
- Cancer immunotherapy (1)
- Carcinoma cells (1)
- Carcinomatosis (1)
- Central venous access (1)
- Central venous-pressure (1)
- Chemotherapeutic resistance (1)
- Class II antigen blockade (1)
- Claudin2 (1)
- Cognitive (1)
- Coronary artery bypass graft (1)
- Coronavirus Disease 2019 (1)
- Critically-ill patients (1)
- Crohn’s Disease (1)
- Crohn’s disease (1)
- Cryolesion (1)
- Cushing (1)
- DNA repair (1)
- Danish hernia database (1)
- Diabetes (1)
- Dickdarmkrebs (1)
- Dsg2 (1)
- Dünndarm (1)
- EDS (1)
- EHS classification (1)
- ERK (1)
- Ehlers-Danlos syndrome (1)
- Elective cesarean-section (1)
- Electrical impedance tomography (1)
- EndoVAC and small bowel (1)
- Epstein-Barr virus (1)
- Experimental brain trauma (1)
- Expression (1)
- Extra-anatomical (1)
- FWGE (1)
- Fascia transversalis (1)
- FcγR (1)
- Femoral vein (1)
- Fibroblasts (1)
- Fluorouracil (1)
- Foxp3 (1)
- GDNF5 (1)
- GIST (1)
- GLP-1 (1)
- General anaesthesia (1)
- Groin infection (1)
- Growth-factor receptor (1)
- Göttingen (1)
- HBMEC (1)
- Heterotransplantation (1)
- Hickman catheter (1)
- High-fat diet (1)
- Hypertonic saline 7.5-percent (1)
- IL-6 (1)
- IVF-methods (1)
- Ileal conduit (1)
- Ileum-Conduit (1)
- Immunologie (1)
- Immunosenescence (1)
- Immunotherapy (1)
- Improved survival (1)
- In vitro models (1)
- Inhibition (1)
- Invasion (1)
- Inzisionale Hernie (1)
- Inzisionalhernie (1)
- KIT (1)
- Kono-S anastomosis (1)
- LAMN (1)
- LND (1)
- LNE (1)
- Lactated ringers solution (1)
- Laparoscopy (1)
- Leistenhernie (1)
- Leptin (1)
- Lernkurve (1)
- Linea alba (1)
- Low-fat diet (1)
- LyP (1)
- Lymph nodes (1)
- MAPK pathway (1)
- MAPK signaling cascades (1)
- MHC I (1)
- MHC Klasse II (1)
- MHC-Klass I (1)
- MITF (1)
- MIZ1 (1)
- MPFL (1)
- MRI (1)
- MTL30 (1)
- MYC (1)
- Major abdominal surgery (1)
- Makrophage (1)
- Mammalian target (1)
- Matrix (1)
- Melanom (1)
- Melanoma (1)
- Merkel cell carcinoma (1)
- Merkelzellkarzinom (1)
- Mesh Augmentation (1)
- Metastatic breast cancer (1)
- Mice (1)
- Minimalinvasiv (1)
- Minimalinvasive Leistenhernienversorgung (1)
- Minimally invasive surgery (1)
- Minischwein (1)
- Modifizierte Sugarbaker-Technik (1)
- Monoclonal antibody (1)
- Multicenter randomized-trial (1)
- NASH (1)
- NPWT (1)
- Niere (1)
- Obturator bypass (1)
- Oncology (1)
- Organoids (1)
- Organtransplantation (1)
- P-glycoprotein (1)
- PCI (1)
- PCR (1)
- PDE (1)
- PDE4-I (1)
- PDGF (1)
- PET (1)
- PET imaging (1)
- PI-3-kinase (1)
- PI3K/Akt/mTOR (1)
- PLAG1 rearrangement (1)
- POEM (1)
- PYY3-36 (1)
- Parastomale Hernie (1)
- Pathway (1)
- Pauli procedure (1)
- Pauli-Verfahren (1)
- Pediatric malignancy (1)
- Peptidanaloge (1)
- Port (1)
- Posteriore Komponentenseparation (1)
- Postoperative complications (1)
- Predict fluid responsiveness (1)
- Primary hyperparathyroidism (pHPT) (1)
- Pulmonary function tests (1)
- Puls-pressure variation (1)
- RET6 (1)
- RNAPOL1 (1)
- RYGB (1)
- Radical prostatectomy (1)
- Radiochemotherapy (1)
- Randomized controlled-trial (1)
- Ratte (1)
- Regulatorischer T-Lymphozyt (1)
- Regulatory T cells (1)
- Retromuskuläres Netz (1)
- Retrorektus Netz (1)
- Robotik (1)
- Roux-en-Y gastric bypass (1)
- SSI (1)
- ST18 (1)
- Secondary traumatic brain damage (1)
- Serom (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- Surgical and invasive medical procedures (1)
- Surgical oncology (1)
- T cell receptors (1)
- T cells (1)
- TCR (1)
- TCR signaling cascade (1)
- TEER (1)
- TLR2 (1)
- TLR4 (1)
- TLR7 (1)
- TLR8 (1)
- TLR9 (1)
- TME (1)
- TNF (1)
- TNF receptor superfamily (1)
- TREC (1)
- Telomere (1)
- Thrombosis (1)
- Time interval (1)
- Tissue (1)
- Toll-like receptor signaling (1)
- Toll-like-Rezeptoren (1)
- Trichternetz (IPST) (1)
- Tumorerkrankungen (1)
- Umbilikalhernie (1)
- Up-regulation (1)
- V. saphena magna (1)
- VAC (1)
- VLBW (1)
- Ventrale Hernie (1)
- Y-gastric bypass (1)
- ZfKD (1)
- Zucker fatty fa/fa rats (1)
- [11C]-Choline PET/CT (1)
- [11C]-Methionine (1)
- [18F]FDG-PET-CT (1)
- [99mTc]-Sestamibi scan (1)
- abdominal compartment syndrome (1)
- abdominal lymph node metastases (1)
- abdominal surgery (1)
- abdominal trauma (1)
- abdominal wall hernia (1)
- abdominal wall surgery (1)
- accumulation (1)
- achalasia (1)
- acute (1)
- acute appendicitis (1)
- acute kidney injury (1)
- acute liver failure (1)
- acute respiratory distress syndrome (1)
- adipose-derived stromal/stem cells (ASCs) (1)
- adiposity (1)
- adjuvant (1)
- adrenal cancer (1)
- adrenal surgery (1)
- adrenal tumors (1)
- adrenalectomia (1)
- adrenocortical (1)
- adrenocortical adenocarcinoma (1)
- allograft rejection (1)
- allopeptide (1)
- alternative splicing (1)
- alveolar epithelium (1)
- anal atresia (1)
- anaplastic large cell lymphoma (1)
- anastomosis (1)
- anastomotic leak (1)
- anorectal abscess (1)
- anorectal angl (1)
- anorectal malformation (1)
- anti-tumor effects (1)
- antibiotic prescribing quality (1)
- antibiotic prescription behavior (1)
- antibiotic resistance (1)
- antibiotics (1)
- antithrombotic therapy (1)
- appendectomy (1)
- appendicitis (1)
- appendix (1)
- assisted reproductive techniques (1)
- autophagy (1)
- barrier models (1)
- benzoquinone (1)
- beta cells (1)
- biliopancreatic diversion (1)
- biological models (1)
- birth defects (1)
- bladder (1)
- blood (1)
- blood samples (1)
- blood-nerve barrier (1)
- blood–brain barrier (1)
- body fat (1)
- body mass index (BMI; kg/m\(^2\)) (1)
- body weight (1)
- bone marrow (1)
- brain metastases (1)
- brain plasticity (1)
- breast cancer (1)
- bronchopulmonary dysplasia (1)
- brown adipose tissue (1)
- bullae (1)
- burst abdomen (1)
- caco-2 cells (1)
- cadaver multiorgan preservation (1)
- caloric-restriction (1)
- cancer cells (1)
- cancer diagnosis (1)
- cancer risk (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- capture (1)
- carcinogenesis (1)
- carcinoma metastases to pancreas (1)
- carcinomas (1)
- cardiogenic (1)
- catheterization (1)
- catheters (1)
- cell cycle and cell division (1)
- cellular senescence (1)
- cerebEND (1)
- cerebral metastases (1)
- chemistry (1)
- chemokine receptor (1)
- children (1)
- children born (1)
- cholestasis (1)
- chylomicron (1)
- colloids (1)
- colon (1)
- colon cancer (1)
- colon carcinoma cells (1)
- colon resection (1)
- colorectal carcinoma (1)
- comet assay (1)
- complications (1)
- computed tomography angiography (CTA) (1)
- congenital malformations (1)
- continuous extracorporeal femoral perfusion model (1)
- conventional laparoscopic appendectomy (1)
- cord blood (1)
- cost-effectiveness (1)
- cotransporter SGLT1 (1)
- creatinine (1)
- curative resection (1)
- cytostatic (1)
- cytotoxicity (1)
- dass II antigen blockade (1)
- deconstruction into key steps (1)
- definition (1)
- dendritische Zellen (1)
- descriptive epidemiology (1)
- desmoglein (1)
- dexamethasone (1)
- diabetes (1)
- diagnosis (1)
- diagnostics (1)
- digital subtraction angiography (DSA) (1)
- discharge definition (1)
- drug-eluting beads (1)
- dual-room whole-body CT (1)
- duodenal jejunal bypass (1)
- duodenal perforation (1)
- duodenal trauma (1)
- elective surgery (1)
- endoscopic (1)
- endoscopic full thickness resection (eFTR) (1)
- endoscopic groin hernia repair (1)
- endosponge (1)
- endotoxemia (1)
- endovascular repair (1)
- energy homeostasis (1)
- enteric glial cells (1)
- enteric nervous system (1)
- enteroids (1)
- ephitelial cells (1)
- epidemiology (1)
- epidural block (1)
- epigastric hernia (1)
- epithelial cells (1)
- epithelium (1)
- esophageal perforation (1)
- expenditure (1)
- experimental models of disease (1)
- experimental therapy (1)
- extremity trauma (1)
- fascial closure (1)
- fat absorption (1)
- fat appetite (1)
- fatty liver (1)
- femoral arteries (1)
- femoral hernia (1)
- fish bone (1)
- fistulizing Crohn’s Disease (1)
- flow cytometry (1)
- focused surgical approach (1)
- folinic acid (1)
- food intake (1)
- foreign body ingestion (1)
- fracture-associated vascular damage (1)
- full-thickness resection device (FTRD) (1)
- funnel mesh (IPST) (1)
- gastric-bypass surgery (1)
- gastrointestinal cancer (1)
- gastrointestinal infections (1)
- gastrointestinal perforation (1)
- gastrointestinal tract (1)
- gemcitabine (1)
- gene regulation (1)
- generation (1)
- geriatric (1)
- germline mutation (1)
- glucagon like peptide-1 (1)
- glucocorticoid receptor (1)
- glucose homeostasis (1)
- glucose metabolism (1)
- glucose starvation (1)
- groin hernia (1)
- growth differentiation factor 15 (1)
- gut hormones (1)
- hematology (1)
- hemorrhagic (1)
- henoch-schönlein purpura (1)
- hepatic resection (1)
- hepatocellular carcinoma (1)
- hernia (1)
- hernia defect (1)
- hernia repair material (1)
- histologic diversity (1)
- histopathology (1)
- human biomonitoring (1)
- human cancer (1)
- human melanoma (1)
- hypersensitivity (1)
- hypothalamic gene expression (1)
- hypoxia (1)
- idiopathic fecal incontinence (1)
- imaging (1)
- immaturity (1)
- immundominant (1)
- immune check inhibitor (1)
- immune response (1)
- immunity (1)
- immunodominant (1)
- immunosuppression (1)
- immunotherapeutics (1)
- impedance spectroscopy (1)
- imperforate anus (1)
- in vitro model (1)
- in vivo (1)
- in-vitro fertilization (1)
- incisional abdominal wall hernia (1)
- induced obesity (1)
- infants born (1)
- inflammation-induced tissue demage (1)
- inflammatory cell model (1)
- inguinal hernia (1)
- inguinal lymph node dissection (1)
- insulin resistance (1)
- intercellular junctions (1)
- intestinal barrier (1)
- intestinal glucose (1)
- intestinal microbiota (1)
- intestinal organoids (1)
- intestine (1)
- intraabdominal abscess (1)
- intragastric balloon (1)
- intravascular ultrasound (IVUS) (1)
- intravenous glucose tolerance test (1)
- ionizing radiation (1)
- irinotecan (1)
- islet transplantation (1)
- isocaloric intake (1)
- isosteviol sodium (STVNA) (1)
- kappa-B (1)
- ketogenic dients (1)
- ketogenic diet (1)
- ketone bodies (1)
- kidney (1)
- kidneys (1)
- la antigens (1)
- laparoscopic appendectomy (1)
- laparoscopic course (1)
- laparoscopic right colectomy (1)
- laparoscopic skills (1)
- laparoscopy (1)
- late onset sepsis (1)
- learning curve (1)
- left hemicolectomy (1)
- leptin (1)
- leptin system (1)
- leukemia (1)
- level of evidence: IV (1)
- linea alba (1)
- lipoblastoma (1)
- lipodystrophy (1)
- liver resection (1)
- locally advanced disease (1)
- low molecular heparin (1)
- low-grade mucinous neoplasm (1)
- low-molecular heparin (1)
- low-risk intra-abdominal infections (1)
- lung resection (1)
- lymph node dissection (1)
- lymph nodes (1)
- lymphadenectomy (1)
- lymphomatoid papulosis (1)
- magnetic resonance imaging (1)
- maintain immune homeostasis (1)
- management (1)
- mass (1)
- mastocytosis (1)
- measles virus (1)
- medial patellofemoral ligament (1)
- meningitis (1)
- mesenchymal stem cells (1)
- mesh augmentation (1)
- mesh repair (1)
- metaanalysis (1)
- metabolic profile (1)
- metabolically unhealthy obesity (1)
- metabolism (1)
- metachronous (1)
- miRNA expression (1)
- mice (1)
- microbiota (1)
- mild hypothermia (1)
- minimally invasive (1)
- modified Sugarbaker technique (1)
- mold exposure (1)
- molecular diagnostics (1)
- monocyte subsets (1)
- monocytes (1)
- mortality rate (1)
- mucormycosis (1)
- mucosal healing (MH) (1)
- multimodal (1)
- myeloid (1)
- nab-paclitaxel (1)
- negative pressure wound therapy (1)
- neoadjuvant (1)
- neoadjuvant chemotherapy (1)
- neonatal immunology (1)
- neonatal meningitis (1)
- neonatal outcome (1)
- netrin-1 (1)
- neuroblastoma – diagnosis (1)
- neuroendocrine tumor (NET) (1)
- neuroinflammation (1)
- neuropathic pain (1)
- neurotrophic factors (1)
- noradrenaline (1)
- noradrenaline transporter (1)
- novel human cadaveric perfusion model (1)
- obesity surgery (1)
- octogenarians (1)
- octogenerians (1)
- older adult (1)
- oncogene-induced senescence (1)
- open appendectomy (1)
- open wound treatment (1)
- operative (1)
- oral anticoagulants (1)
- organoid (1)
- outcome (1)
- pancreas Islets (1)
- pancreatectomy (1)
- pancreatic adenocarcinoma (PDAC) (1)
- pancreatic head cancer (1)
- parathyroid adenoma (1)
- parathyroid carcinoma (1)
- patella alta (1)
- patella dislocation (1)
- patella instability (1)
- pathway analysis (1)
- patient-derived organoid (PDOs) (1)
- patient-derived tumor organoid (PDTO) (1)
- pediatric adrenocortical adenoma (1)
- pediatric adrenocortical cancer (1)
- pediatric adrenocortical tumor (1)
- pelvic trauma (1)
- pembrolizumab (1)
- pemphigus (1)
- penetrating ileitis (1)
- peptide analogs (1)
- peptide tyrosine tyrosine 3-36 (PYY3-36) (1)
- peptide tyrosine tyrosine 3-36 (PYY\(_{3-36}\)) (1)
- perianal fistulas (1)
- perioperative antibiotic prophylaxis (1)
- perioperative chemotherapy (1)
- periphery-brain interactions (1)
- peritonitis (1)
- permeability (1)
- peroral endoscopic myotomy (1)
- phosphodiesterase-4 (1)
- phosphodiesterase-inhibitors (1)
- photon-counting computed tomography (CT) (1)
- pig or swine (1)
- platelet dysfunction (1)
- popliteal aneurysm (1)
- positron emission tomography imaging (1)
- post-mortem heart recovery (1)
- post-operative antibiotic treatment (1)
- posterior component separation (1)
- postoperative inflammation (1)
- preclinical research (1)
- preoperative localization (1)
- preterm birth (1)
- prevalence (1)
- primary hyperparathyroidism (1)
- primär ventrale Hernie (1)
- prognosis (1)
- prognostic factors (1)
- prospective studies (1)
- protein expression (1)
- protein kinase D2/PKD2/PRKD2 (1)
- protein synthesis (1)
- quality of life (1)
- radiotracer (1)
- reactivating p53 and inducing tumor apoptosis (RITA) (1)
- reactive oxygen (1)
- reactive oxygen species (1)
- real-time glucose monitoring (1)
- rectal cancer (1)
- rectal resection (1)
- recurrence survival (1)
- recurrent abdominal wall hernia (1)
- regeneration (1)
- regenerative medicine (1)
- regional recurrence (1)
- regionalization and organoids (1)
- registries (1)
- regulatory T cells (1)
- renal transplantation (1)
- repeat surgery (1)
- repeated surgery (1)
- reproductive medicine (1)
- resuscitation time (1)
- retromuscular mesh (1)
- retroperitoneal tumor (1)
- retrorectus mesh (1)
- retrospective study (1)
- reverse transcriptase-polymerase chain reaction (1)
- review (1)
- ribosome (1)
- risk factor (1)
- risk factors (1)
- robotic surgery (1)
- robotic surgical procedures (1)
- rolipram (1)
- rygb (1)
- sacral nerve stimulation (1)
- sacral neuromodulation (1)
- screening (1)
- seahorse (1)
- secondary skin closure (1)
- secretion (1)
- seminoma (1)
- septic (1)
- seroma (1)
- serotonin (1)
- serotonin transporter (1)
- shock (1)
- single-port appendectomy (1)
- sleeve gastrectomy (1)
- small bowel (1)
- small interferring RNA (1)
- small pixel effect (1)
- streptozotocin (1)
- super-obesity (1)
- superior (1)
- surgical (1)
- surgical and invasive medical procedures (1)
- surgical care (1)
- surgical complications (1)
- surgical intra-abdominal infections (1)
- surgical management (1)
- surgical oncology (1)
- surgical outcome (1)
- surgical procedures (1)
- surgical resection (1)
- surgical site infection (1)
- surgical site infections (1)
- surgical trauma room (1)
- surgical treatment (1)
- survival (1)
- survival analysis (1)
- sympathetic nervous system (1)
- systematic review (1)
- systemic and cutaneous CD30+ lymphoproliferations (1)
- systemic endotoxemia (1)
- teaching methods (1)
- technology (1)
- terminal ileitis (1)
- thermogenesis (1)
- thyroid gland (1)
- thyroiditis (1)
- tight junction (1)
- tight junction proteins (1)
- tissue (1)
- tolerance (1)
- total pancreatectomy (1)
- transanal endoscopic microsurgery (TEM) (1)
- transarterial chemoembolization (1)
- translation initiation (1)
- transplant (1)
- transplantation (1)
- transstomal endoluminal vacuum therapy (1)
- transverse fascia (1)
- trauma centre (1)
- trauma management (1)
- trochlear dysplasia (1)
- trophic factors (1)
- tumor disease (1)
- tumor growth (1)
- type 2 diabetes (1)
- ultrahigh resolution (1)
- uncoupling protein 1 (1)
- urinary tract infections (1)
- urine (1)
- vascular type (1)
- vasculitis (1)
- ventral hernia model (1)
- visceral fat (1)
- vitamin D (1)
- volume (1)
- warfarin interruption (1)
- weight-gain (1)
- wound infection (1)
- xenogeneic transplantation (1)
- xenogenic transplantation (1)
- β-Hydroxybutyrate (1)
Institute
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (229) (remove)
Sonstige beteiligte Institutionen
Background: The use of assisted reproductive techniques (ART) for treatment of infertility is increasing rapidly worldwide. However, various health effects have been reported including a higher risk of congenital malformations. Therefore, we assessed the risk of anorectal malformations (ARM) after in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).
Methods: Data of the German Network for Congenital Uro-REctal malformations (CURE-Net) were compared to nationwide data of the German IVF register and the Federal Statistical Office (DESTATIS). Odds ratios (95% confidence intervals) were determined to quantify associations using multivariable logistic regression accounting for potential confounding or interaction by plurality of births.
Results: In total, 295 ARM patients born between 1997 and 2011 in Germany, who were recruited through participating pediatric surgeries from all over Germany and the German self-help organisation SoMA, were included. Controls were all German live-births (n = 10,069,986) born between 1997 and 2010. Overall, 30 cases (10%) and 129,982 controls (1%) were born after IVF or ICSI, which translates to an odds ratio (95% confidence interval) of 8.7 (5.9-12.6) between ART and ARM in bivariate analyses. Separate analyses showed a significantly increased risk for ARM after IVF (OR, 10.9; 95% CI, 6.2-19.0; P < 0.0001) as well as after ICSI (OR, 7.5; 95% CI, 4.6-12.2; P < 0.0001). Furthermore, separate analyses of patients with isolated ARM, ARM with associated anomalies and those with a VATER/VACTERL association showed strong associations with ART (ORs 4.9, 11.9 and 7.9, respectively). After stratification for plurality of birth, the corresponding odds ratios (95% confidence intervals) were 7.7 (4.6-12.7) for singletons and 4.9 (2.4-10.1) for multiple births. Conclusions: There is a strongly increased risk for ARM among children born after ART. Elevations of risk were seen after both IVF and ICSI. Further, separate analyses of patients with isolated ARM, ARM with associated anomalies and those with a VATER/VACTERL association showed increased risks in each group. An increased risk of ARM was also seen among both singletons and multiple births.
Fibroblast growth factor-inducible 14 (Fn14) is a member of the tumor necrosis factor (TNF) receptor superfamily (TNFRSF) and is activated by its ligand TNF-like weak inducer of apoptosis (TWEAK). The latter occurs as a homotrimeric molecule in a soluble and a membrane-bound form. Soluble TWEAK (sTWEAK) activates the weakly inflammatory alternative NF-κB pathway and sensitizes for TNF-induced cell death while membrane TWEAK (memTWEAK) triggers additionally robust activation of the classical NF-κB pathway and various MAP kinase cascades. Fn14 expression is limited in adult organisms but becomes strongly induced in non-hematopoietic cells by a variety of growth factors, cytokines and physical stressors (e.g., hypoxia, irradiation). Since all these Fn14-inducing factors are frequently also present in the tumor microenvironment, Fn14 is regularly found to be expressed by non-hematopoietic cells of the tumor microenvironment and most solid tumor cells. In general, there are three possibilities how the tumor-Fn14 linkage could be taken into consideration for tumor therapy. First, by exploitation of the cancer associated expression of Fn14 to direct cytotoxic activities (antibody-dependent cell-mediated cytotoxicity (ADCC), cytotoxic payloads, CAR T-cells) to the tumor, second by blockade of potential protumoral activities of the TWEAK/Fn14 system, and third, by stimulation of Fn14 which not only triggers proinflammtory activities but also sensitizes cells for apoptotic and necroptotic cell death. Based on a brief description of the biology of the TWEAK/Fn14 system and Fn14 signaling, we discuss the features of the most relevant Fn14-targeting biologicals and review the preclinical data obtained with these reagents. In particular, we address problems and limitations which became evident in the preclinical studies with Fn14-targeting biologicals and debate possibilities how they could be overcome.
Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity
(2023)
Fibroblast growth factor (FGF)-inducible 14 (Fn14) activates the classical and alternative NFκB (nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells) signaling pathway but also enhances tumor necrosis factor (TNF)-induced cell death. Fn14 expression is upregulated in non-hematopoietic cells during tissue injury and is also often highly expressed in solid cancers. In view of the latter, there were and are considerable preclinical efforts to target Fn14 for tumor therapy, either by exploiting Fn14 as a target for antibodies with cytotoxic activity (e.g. antibody-dependent cellular cytotoxicity (ADCC)-inducing IgG variants, antibody drug conjugates) or by blocking antibodies with the aim to interfere with protumoral Fn14 activities. Noteworthy, there are yet no attempts to target Fn14 with agonistic Fc effector function silenced antibodies to unleash the proinflammatory and cell death-enhancing activities of this receptor for tumor therapy. This is certainly not at least due to the fact that anti-Fn14 antibodies only act as effective agonists when they are presented bound to Fcγ receptors (FcγR). Thus, there are so far no antibodies that robustly and selectively engage Fn14 signaling without triggering unwanted FcγR-mediated activities. In this study, we investigated a panel of variants of the anti-Fn14 antibody 18D1 of different valencies and domain architectures with respect to their inherent FcγR-independent ability to trigger Fn14-associated signaling pathways. In contrast to conventional 18D1, the majority of 18D1 antibody variants with four or more Fn14 binding sites displayed a strong ability to trigger the alternative NFκB pathway and to enhance TNF-induced cell death and therefore resemble in their activity soluble (TNF)-like weak inducer of apoptosis (TWEAK), one form of the natural occurring ligand of Fn14. Noteworthy, activation of the classical NFκB pathway, which naturally is predominately triggered by membrane-bound TWEAK but not soluble TWEAK, was preferentially observed with a subset of constructs containing Fn14 binding sites at opposing sites of the IgG scaffold, e.g. IgG1-scFv fusion proteins. A superior ability of IgG1-scFv fusion proteins to trigger classical NFκB signaling was also observed with the anti-Fn14 antibody PDL192 suggesting that we identified generic structures for Fn14 antibody variants mimicking soluble and membrane-bound TWEAK.
Objective: To investigate the impact of the phophodiesterase-4 inhibition (PD-4-I) with rolipram on hepatic integrity in lipopolysaccharide (LPS) induced hyperinflammation. Materials and Methods: Liver microcirculation in rats was obtained using intravital microscopy. Macrohemodynamic parameters, blood assays, and organs were harvested to determine organ function and injury. Hyperinflammation was induced by LPS and PD-4-I rolipram was administered intravenously one hour after LPS application. Cell viability of HepG2 cells was measured by EZ4U-kit based on the dye XTT. Experiments were carried out assessing the influence of different concentrations of tumor necrosis factor alpha (TNF-α) and LPS with or without PD-4-I. Results: Untreated LPS-induced rats showed significantly decreased liver microcirculation and increased hepatic cell death, whereas LPS + PD-4-I treatment could improve hepatic volumetric flow and cell death to control level whithout influencing the inflammatory impact. In HepG2 cells TNF-α and LPS significantly reduced cell viability. Coincubation with PD-4-I increased HepG2 viability to control levels. The heme oxygenase 1 (HO-1) pathway did not induce the protective effect of PD-4-I. Conclusion: Intravenous PD-4-I treatment was effective in improving hepatic microcirculation and hepatic integrity, while it had a direct protective effect on HepG2 viability during inflammation.
Because successful human islet transplantation requires large quantities of viable islets that must be separated from the highly immunogenic exocrine tissue and because handpicking is too time-consuming and laborious to be clinically relevant, a new approach for solving this problem has been established in rat models. It is based on the principle that magnetic microspheres (MMSs) coupled to lectins with binding specificity for the exocrine tissue portion are trapped in an electromagnetic field, thus providing effluent islets of a high degree of purity. In this study our aim was to adapt this princip'le to human islet preparations. In this context our prime interest was focused on a lectin suitable for human pancreatic tissue. Of 19 different lectins tested, only 1, Wisteria floribunda agglutinin (WFA), is suitable, as shown by immunofluorescence, MMS-Iectin binding, and magnetic separation